International audienceWe report the emergence of an atpE mutation in a clinical Mycobacterium tuberculosis strain. Genotypic and phenotypic bedaquiline susceptibility testing displayed variable results over time and ultimately were not predictive of treatment outcome. This observation highlights the limits of current genotypic and phenotypic methods for detection of bedaquiline resistance. © 2022 Centers for Disease Control and Prevention (CDC). All rights reserved
Abstract Background Mutations in the Rv0678, pepQ and atpE genes of Mycobacterium tuberculosis (MTB)...
Abstract Drug-resistant tuberculosis is a serious global health threat. Bedaquiline (BDQ) is a relat...
Bedaquiline, clofazimine and linezolid are pertinent drugs for drug-resistant tuberculosis. Drug-res...
International audienceWe report the emergence of an atpE mutation in a clinical Mycobacterium tuberc...
Bedaquiline resistance within Mycobacterium tuberculosis may arise through efflux-based (rv0678) or ...
Clinical resistance against Bedaquiline, the first new anti-tuberculosis compound with a novel mecha...
Bedaquiline resistance within Mycobacterium tuberculosis may arise through efflux-based (rv0678) or ...
BACKGROUND: Bedaquiline is a crucial drug for control of rifampicin-resistant tuberculosis. Molecula...
Clinical resistance against Bedaquiline, the first new anti-tuberculosis compound with a novel mecha...
Bedaquiline resistance within Mycobacterium tuberculosis may arise through efflux-based (rv0678) or ...
Tuberculosis (TB) is one of the major causes of death related to antimicrobial resistance worldwide ...
Bedaquiline, a new anti-tuberculosis drug, has already been used in more than 50 countries. The emer...
Summary: Background: Bedaquiline is a crucial drug for control of rifampicin-resistant tuberculosis...
Bedaquiline, a new antituberculosis drug, has already been used in >50 countries. The emergence of b...
Bedaquiline, a new antituberculosis drug, has already been used in >50 countries. The emergence of b...
Abstract Background Mutations in the Rv0678, pepQ and atpE genes of Mycobacterium tuberculosis (MTB)...
Abstract Drug-resistant tuberculosis is a serious global health threat. Bedaquiline (BDQ) is a relat...
Bedaquiline, clofazimine and linezolid are pertinent drugs for drug-resistant tuberculosis. Drug-res...
International audienceWe report the emergence of an atpE mutation in a clinical Mycobacterium tuberc...
Bedaquiline resistance within Mycobacterium tuberculosis may arise through efflux-based (rv0678) or ...
Clinical resistance against Bedaquiline, the first new anti-tuberculosis compound with a novel mecha...
Bedaquiline resistance within Mycobacterium tuberculosis may arise through efflux-based (rv0678) or ...
BACKGROUND: Bedaquiline is a crucial drug for control of rifampicin-resistant tuberculosis. Molecula...
Clinical resistance against Bedaquiline, the first new anti-tuberculosis compound with a novel mecha...
Bedaquiline resistance within Mycobacterium tuberculosis may arise through efflux-based (rv0678) or ...
Tuberculosis (TB) is one of the major causes of death related to antimicrobial resistance worldwide ...
Bedaquiline, a new anti-tuberculosis drug, has already been used in more than 50 countries. The emer...
Summary: Background: Bedaquiline is a crucial drug for control of rifampicin-resistant tuberculosis...
Bedaquiline, a new antituberculosis drug, has already been used in >50 countries. The emergence of b...
Bedaquiline, a new antituberculosis drug, has already been used in >50 countries. The emergence of b...
Abstract Background Mutations in the Rv0678, pepQ and atpE genes of Mycobacterium tuberculosis (MTB)...
Abstract Drug-resistant tuberculosis is a serious global health threat. Bedaquiline (BDQ) is a relat...
Bedaquiline, clofazimine and linezolid are pertinent drugs for drug-resistant tuberculosis. Drug-res...